Physician profile
Mark Perry
NPI 1437114402
$4,526.32
in general payments reported to CMS, 2019-2025
12 companies · $84.68 in 2025
The $84.68 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $135 · 2021: $141 · 2022: $103 · 2023: $2,147 · 2024: $575 · 2025: $84.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,074 · Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,073.78 |
| Food and Beverage | $732.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,321.11 | 2019 | |
| Stryker Corporation | $1,234.62 | 2021-2025 | Augment Injectable, Prostep, Variax |
| Arthrex, INC. | $1,159.41 | 2023 | Distal Extremities Implants Soft Tissue Anchors |
| Supreme Orthopedic Systems, LLC | $457.32 | 2023-2024 | |
| Depuy Synthes Sales INC. | $121.87 | 2020 | |
| Ossio INC | $66.47 | 2022 | |
| Orthofix Medical, INC. | $42.06 | 2023 | Physio-Stim, Spinal-Stim |
| Pacira Pharmaceuticals Incorporated | $39.95 | 2024 | Iovera, Zilretta, Exparel |
| Abbott Laboratories | $26.18 | 2025 | Proclaim |
| Bioventus LLC | $25.08 | 2022 | |
| Pacira Therapeutics, INC. | $18.67 | 2019 | |
| Acell, INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.